Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
R-CHOEP-14 regimen
Introduction
Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Etoposide-Prednisone regimen
Overview
Overview
R-CHOEP-14 regimen refers to a two-week regimen consisting of rituximab,cyclophosphamide, doxorubicin (hydroxydaunorubicin, vincristine (Oncovin), etoposide, and prednisone used to treat diffuse large B-cell lymphoma.[1]
Regimen
Regimen
RRituximab
CCyclophosphamide
HDoxorubicin (Hydroxydaunomycin)
OVincristine (Oncovin)
EEtoposide
PPrednisone
References
References
- ↑ 1.0 1.1 Gang AO, Strøm C, Pedersen M, d’Amore F, Pedersen LM, Bukh A; et al. (2012). “R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group”. Ann Oncol. 23 (1): 147–53. doi:10.1093/annonc/mdr058. PMID 21460380.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]